Encompass Health (EHC) Rating Reiterated by Piper Jaffray Companies
Several other equities research analysts have also recently issued reports on EHC. Stephens set a $62.00 price objective on Encompass Health and gave the stock a buy rating in a report on Tuesday, February 27th. Royal Bank of Canada lifted their price objective on Encompass Health to $64.00 and gave the stock an outperform rating in a report on Thursday. Credit Suisse Group lifted their price objective on Encompass Health from $58.00 to $61.00 and gave the stock an outperform rating in a report on Tuesday, February 27th. SunTrust Banks set a $58.00 target price on shares of Encompass Health and gave the stock a buy rating in a research note on Thursday, December 21st. Finally, Wells Fargo & Co initiated coverage on shares of Encompass Health in a research note on Tuesday, January 30th. They issued a market perform rating and a $56.00 target price on the stock. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and eight have issued a buy rating to the stock. The stock has a consensus rating of Hold and a consensus price target of $58.00.
Shares of Encompass Health (AMEX:EHC) opened at $55.08 on Thursday. The company has a quick ratio of 1.34, a current ratio of 1.34 and a debt-to-equity ratio of 1.89. Encompass Health has a twelve month low of $40.86 and a twelve month high of $56.13. The stock has a market capitalization of $5,410.00, a PE ratio of 20.32, a P/E/G ratio of 1.70 and a beta of 0.48.
The firm also recently announced a quarterly dividend, which will be paid on Monday, April 16th. Shareholders of record on Monday, April 2nd will be paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 1.82%. The ex-dividend date is Thursday, March 29th. Encompass Health’s dividend payout ratio (DPR) is 36.90%.
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. FNY Managed Accounts LLC purchased a new position in Encompass Health in the 4th quarter worth approximately $125,000. Cerebellum GP LLC purchased a new stake in shares of Encompass Health during the 4th quarter valued at approximately $129,000. Heartland Advisors Inc. purchased a new stake in shares of Encompass Health during the 4th quarter valued at approximately $237,000. Zeke Capital Advisors LLC purchased a new stake in shares of Encompass Health during the 4th quarter valued at approximately $238,000. Finally, S. R. Schill & Associates purchased a new stake in shares of Encompass Health during the 4th quarter valued at approximately $401,000. 93.18% of the stock is currently owned by institutional investors and hedge funds.
About Encompass Health
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.